Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.87	8.74	12.62	13.16	63.46	16.46
Short-Term Investments	62.82	43.22	14.53	29.14	5.99	27.8
Cash & Short-Term Investments	65.69	51.96	27.15	42.3	69.45	44.26
Cash Growth	57.71%	91.40%	-35.82%	-39.09%	56.92%	-43.24%
Accounts Receivable	0.03	0.08	0.03	0.59	0.51	-
Other Current Assets	1.22	2.37	0.78	0.77	1.35	1.08
Total Current Assets	66.94	54.41	27.96	43.66	71.31	45.34
Net Property, Plant & Equipment	1.15	1.33	1.39	2.57	3.64	2.55
Long-Term Investments	11.53	12.54	16.12	21.88	34.27	37.23
Other Long-Term Assets	0.85	0.63	0.09	0.13	0.24	0.41
Total Assets	80.47	68.91	45.55	68.24	109.46	85.53
Accounts Payable	1.97	2.58	1.53	1.98	1.57	3.47
Accrued Expenses	5.72	3.73	3.97	7.55	7.08	7.6
Current Portion of Leases	0.38	0.19	1.37	1.23	1.05	1.08
Other Current Liabilities	-	28.91	-	-	-	-
Total Current Liabilities	8.07	35.4	6.87	10.75	9.69	12.15
Long-Term Leases	0.63	0.94	-	1.37	2.6	1.23
Total Long-Term Liabilities	0.63	0.94	-	1.37	2.6	1.23
Total Liabilities	8.71	36.34	6.87	12.13	12.29	13.38
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	472.79	430.86	374.36	364.36	361.67	295.28
Accumulated Other Comprehensive Income	-1.06	-1.29	-0.97	-0.56	1.87	0
Retained Earnings	-399.97	-397.01	-334.72	-307.69	-266.38	-223.14
Shareholders' Equity	71.77	32.57	38.68	56.12	97.16	72.15
Total Liabilities & Equity	80.47	68.91	45.55	68.24	109.46	85.53
Total Debt	1.01	1.12	1.37	2.6	3.65	2.31
Net Cash (Debt)	64.68	50.84	25.78	39.7	65.8	41.95
Net Cash Growth	27.21%	97.25%	-35.08%	-39.67%	56.87%	-43.91%
Net Cash Per Share	0.85	0.83	0.54	0.85	1.57	1.42
Book Value	71.77	32.57	38.68	56.12	97.16	72.15
Book Value Per Share	0.94	0.53	0.81	1.21	2.32	2.45
Tangible Book Value	71.77	32.57	38.68	56.12	97.16	72.15
Tangible Book Value Per Share	0.94	0.53	0.81	1.21	2.32	2.45

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q